Neuroblastoma Treatment Market: By Diagnostics (MIBG Scan, Imaging, Urine Analysis, and Biopsy), By Drugs (Crizotinib, Doxorubicin Hydrochloride, Cyclophosphamide, Vincristine Sulfate, and Others), By Treatment (Surgery, Chemotherapy, High-Dose Chemotherapy with Stem Cell Support, Monoclonal Antibody Treatment, Radiotherapy, and Others), and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Neuroblastoma Treatment Market size was valued at USD 442 billion in 2022 and is poised to grow at a CAGR of 3.6% from 2023-29. The global market provides a detailed overview and that can be segmented by diagnostics, by drugs, and by treatment. By diagnostics, the global neuroblastoma treatment market has been segmented into MIBG Scan, Imaging, Urine Analysis, and Biopsy. The Imaging segment is likely to be the largest and fastest-growing segment in terms of type in 2021 and is expected to maintain the trend in the forecasted years. MIBG scan segment is also growing at a faster rate. Based on drugs, the global neuroblastoma treatment market is segmented Crizotinib, Doxorubicin Hydrochloride, Cyclophosphamide, Vincristine Sulfate, and Others. Among these, the Crizotinib segment is expected to have the fastest-growing market during the forecast period 2022-2028. It is attributed to the efficiency of the drug and high demand in the market. Also, Hydrochloride drugs has high demand in the global market and is expected to grow at a significant CAGR in the upcoming forecasted years. Based on treatment, the global neuroblastoma treatment market is segmented into Surgery, Chemotherapy, High-Dose Chemotherapy with Stem Cells Support, Monoclonal Antibody Treatment, Radiotherapy, and Others. The Surgery segment accounts for the largest share in 2021. Chemotherapy segment is the second-largest share during the forecast period 2022-2028 according to precision business insights. Although, high risk and side effects associated with Chemotherapy is restraining the growth of this segment at a significant rate. Key stakeholders of the market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global neuroblastoma treatment products.

Neuroblastoma Treatment Market Key Developments:

  • In Oct 2022, Cyclacel Pharmaceuticals announced that it will present preliminary dose escalation data from its ongoing 065-101 Phase 1/2 clinical trial of oral fadraciclib.

Global Neuroblastoma Treatment Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

3.6%

Largest Market

North America

Fastest Growing Market

Europe
Neuroblastoma Treatment Market Dynamics

Increasing prevalence of neuroblastoma, rising healthcare expenses, and a greater number of awareness programs on neuroblastoma are anticipated to propel the market growth over the forecast years.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018-2022) and forecast (2023-2029)
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startups details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Neuroblastoma Treatment Market Segmentation

By Diagnostics
  • MIBG Scan
  • Imaging
  • Urine Analysis
  • Biopsy
By Drugs
  • Crizotinib
  • Doxorubicin Hydrochloride
  • Cyclophosphamide
  • Vincristine Sulfate
  • Others
By Treatment
  • Surgery
  • Chemotherapy
  • High-Dose Chemotherapy with Stem Cell Support
  • Monoclonal Antibody Treatment
  • Radiotherapy
  • Others

Frequently Asked Questions

The new pipeline drugs can provide lucrative opportunity in the global market.

Investment in research and development sector to invent new therapies and treatment are the main strategy of the global market players.

High cost and side effects associated with treatment options may hamper the global market growth.

 

  1. Executive Summary
  2. Global Neurological Disorder Diagnostics Market Introduction
    • Global Neurological Disorder Diagnostics Market - Taxonomy
    • Global Neurological Disorder Diagnostics Market -Definitions
      • By Technology
      • By Indication
      • By End User
      • By Region
  1. Global Neurological Disorder Diagnostics Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Neurological Disorder Diagnostics Market Dynamics - Factors Impact Analysis
  2. Global Neurological Disorder Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
    • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global Neurological Disorder Diagnostics Market Forecast, By Technology, 2018 - 2022 and Forecast, 2023 - 2029
    • Imaging
      • Computed Tomography (CT)
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Magnetic Resonance Imaging (MRI)
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Electroencephalography (EEG)
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Single-Photon Emission Computed Tomography (SPECT)
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Nuclear Medicine Imaging
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Magnetoencephalography (MEG)
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Positron Emission Tomography (PET)
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Ultrasound Imaging
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • In-Vitro Diagnostics
        • Biomarker
          • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Biopsy
          • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Others
          • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
  1. Global Neurological Disorder Diagnostics Market Forecast, By Indication, 2018 - 2022 and Forecast, 2023 - 2029
    • Genetic Neurological Disorders
      • Alzheimer's Disease (AD)
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Parkinson's Disease (PD)
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Huntington's Disease (HD)
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Amyotrophic Lateral Sclerosis (ALS)
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Others
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Immunological Neurological Disorders
        • Multiple Sclerosis
          • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Others
          • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Paraneoplastic Syndrome
          • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Paraproteinemic Neuropathies
          • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Others
          • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
  1. Global Neurological Disorder Diagnostics Market Forecast, By End User, 2018 - 2022 and Forecast, 2023 - 2029
    • Hospitals & Clinics
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Diagnostic Centers
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Ambulatory Care Centers
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Neurological Disorder Diagnostics Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029
    • North America
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia Pacific
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • The Middle East & Africa
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Neurological Disorder Diagnostics Market - Opportunity Analysis Index, By Technology, By Indication, By End User, and Region, 2023 - 2029
  2. North America Neurological Disorder Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
    • Technology Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Imaging
        • Computed Tomography (CT)
        • Magnetic Resonance Imaging (MRI)
        • Electroencephalography (EEG)
        • Single-Photon Emission Computed Tomography (SPECT)
        • Nuclear Medicine Imaging
        • Magnetoencephalography (MEG)
        • Positron Emission Tomography (PET)
        • Ultrasound Imaging
      • In-Vitro Diagnostics
        • Biomarker
        • Biopsy
        • Others
      • Indication Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Genetic Neurological Disorders
          • Alzheimer's Disease (AD)
          • Parkinson's Disease (PD)
          • Huntington's Disease (HD)
          • Amyotrophic Lateral Sclerosis (ALS)
          • Others
        • Immunological Neurological Disorders
          • Multiple Sclerosis
          • Others
        • Paraneoplastic Syndrome
        • Paraproteinemic Neuropathies
        • Others
      • End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Hospitals & Clinics
        • Diagnostic Centers
        • Ambulatory Care Centers
      • Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • US.
        • Canada
      • North America Neurological Disorder Diagnostics Market - Opportunity Analysis Index, By Technology, By Indication, By End User, and Country, 2023 - 2029
      • North America Neurological Disorder Diagnostics Market Dynamics - Trends
  1. Europe Neurological Disorder Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
    • Technology Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Imaging
        • Computed Tomography (CT)
        • Magnetic Resonance Imaging (MRI)
        • Electroencephalography (EEG)
        • Single-Photon Emission Computed Tomography (SPECT)
        • Nuclear Medicine Imaging
        • Magnetoencephalography (MEG)
        • Positron Emission Tomography (PET)
        • Ultrasound Imaging
      • In-Vitro Diagnostics
        • Biomarker
        • Biopsy
        • Others
      • Indication Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Genetic Neurological Disorders
          • Alzheimer's Disease (AD)
          • Parkinson's Disease (PD)
          • Huntington's Disease (HD)
          • Amyotrophic Lateral Sclerosis (ALS)
          • Others
        • Immunological Neurological Disorders
          • Multiple Sclerosis
          • Others
        • Paraneoplastic Syndrome
        • Paraproteinemic Neuropathies
        • Others
      • End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Hospitals & Clinics
        • Diagnostic Centers
        • Ambulatory Care Centers
      • Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • UK.
        • Germany
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
      • Europe Neurological Disorder Diagnostics Market - Opportunity Analysis Index, By Technology, By Indication, By End User, and Country, 2023 - 2029
      • Europe Neurological Disorder Diagnostics Market Dynamics - Trends
  1. Asia Pacific Neurological Disorder Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
    • Technology Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Imaging
        • Computed Tomography (CT)
        • Magnetic Resonance Imaging (MRI)
        • Electroencephalography (EEG)
        • Single-Photon Emission Computed Tomography (SPECT)
        • Nuclear Medicine Imaging
        • Magnetoencephalography (MEG)
        • Positron Emission Tomography (PET)
        • Ultrasound Imaging
      • In-Vitro Diagnostics
        • Biomarker
        • Biopsy
        • Others
      • Indication Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Genetic Neurological Disorders
          • Alzheimer's Disease (AD)
          • Parkinson's Disease (PD)
          • Huntington's Disease (HD)
          • Amyotrophic Lateral Sclerosis (ALS)
          • Others
        • Immunological Neurological Disorders
          • Multiple Sclerosis
          • Others
        • Paraneoplastic Syndrome
        • Paraproteinemic Neuropathies
        • Others
      • End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Hospitals & Clinics
        • Diagnostic Centers
        • Ambulatory Care Centers
      • Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • China
        • Japan
        • India
        • ASEAN Counties
        • Philippines
        • Rest of Asia Pacific
      • Asia Pacific Neurological Disorder Diagnostics Market - Opportunity Analysis Index, By Technology, By Indication, By End User, and Country, 2023 - 2029
      • Asia Pacific Neurological Disorder Diagnostics Market Dynamics - Trends
  1. Latin America Neurological Disorder Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
    • Technology Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Imaging
        • Computed Tomography (CT)
        • Magnetic Resonance Imaging (MRI)
        • Electroencephalography (EEG)
        • Single-Photon Emission Computed Tomography (SPECT)
        • Nuclear Medicine Imaging
        • Magnetoencephalography (MEG)
        • Positron Emission Tomography (PET)
        • Ultrasound Imaging
      • In-Vitro Diagnostics
        • Biomarker
        • Biopsy
        • Others
      • Indication Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Genetic Neurological Disorders
          • Alzheimer's Disease (AD)
          • Parkinson's Disease (PD)
          • Huntington's Disease (HD)
          • Amyotrophic Lateral Sclerosis (ALS)
          • Others
        • Immunological Neurological Disorders
          • Multiple Sclerosis
          • Others
        • Paraneoplastic Syndrome
        • Paraproteinemic Neuropathies
        • Others
      • End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Hospitals & Clinics
        • Diagnostic Centers
        • Ambulatory Care Centers
      • Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Mexico
        • Brazil
        • Argentina
        • Chile
        • Rest of Latin America
      • Latin America Neurological Disorder Diagnostics Market - Opportunity Analysis Index, By Technology, By Indication, By End User, and Country, 2023 - 2029
      • Latin America Neurological Disorder Diagnostics Market Dynamics - Trends
  1. Middle East and Africa Neurological Disorder Diagnostics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
    • Technology Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Imaging
        • Computed Tomography (CT)
        • Magnetic Resonance Imaging (MRI)
        • Electroencephalography (EEG)
        • Single-Photon Emission Computed Tomography (SPECT)
        • Nuclear Medicine Imaging
        • Magnetoencephalography (MEG)
        • Positron Emission Tomography (PET)
        • Ultrasound Imaging
      • In-Vitro Diagnostics
        • Biomarker
        • Biopsy
        • Others
      • Indication Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Genetic Neurological Disorders
          • Alzheimer's Disease (AD)
          • Parkinson's Disease (PD)
          • Huntington's Disease (HD)
          • Amyotrophic Lateral Sclerosis (ALS)
          • Others
        • Immunological Neurological Disorders
          • Multiple Sclerosis
          • Others
        • Paraneoplastic Syndrome
        • Paraproteinemic Neuropathies
        • Others
      • End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
        • Hospitals & Clinics
        • Diagnostic Centers
        • Ambulatory Care Centers
      • Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • GCC Countries
        • South Africa
        • Saudi Arabia
        • Turkey
        • Rest of MEA
      • Middle East and Africa Neurological Disorder Diagnostics Market - Opportunity Analysis Index, By Technology, By Indication, By End User, and Country, 2023 - 2029
      • Middle East and Africa Neurological Disorder Diagnostics Market Dynamics - Trends
  1. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Key Developments, Strategies, and SWOT Analysis)
      • Siemens Healthineers
      • Koninklijke Philips N.V.
      • General Electric Company
      • Esaote SpA
      • NeuroLogica Corporation
      • Masimo Corporation
      • York Instruments Ltd.
      • Neusoft Medical Systems
      • Canon Medical Systems Corporation
      • Smith & Nephew Inc
      • Johnson & Johnson
  1. Research End Userology
  2. Key Assumptions and Acronyms
  • Bristol-Myers Squibb
  • Johnson & Johnson
  • Pfizer
  • Teva Pharmaceutical
  • United Therapeutics
  • Amneal Pharmaceuticals, Inc.

Adjacent Markets